Drug intelligence / Profile preview

11C-yohimbine

Development stage
Phase 1
Lead developer
Johns Hopkins University
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

11C-yohimbine is a radiopharmaceutical used as a Positron Emission Tomography (PET) tracer to image and quantify alpha-2 adrenergic receptors in the brain and peripheral tissues. It is a carbon-11 labeled version of yohimbine, a natural alkaloid that acts as a potent and selective alpha-2 adrenergic receptor antagonist. By binding to these receptors, 11C-yohimbine allows researchers to study the density and distribution of alpha-2 receptors in vivo, which is relevant for investigating various neuropsychiatric and cardiovascular conditions, including depression, anxiety, and hypertension. The tracer is primarily used in clinical research settings rather than routine diagnostic practice.

Other names
carbon-11 yohimbinecarbon11 yohimbinecarbon 11 yohimbine[11C]-yohimbine11C-labeled yohimbine
02

Targets

ADRA2B (α2B)ADRA2A (α2A)ADRA2C (α2C)

Beyond the preview

Go deeper on 11C-yohimbine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 11C-yohimbine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call